We found that LTi cells, a subpopulation of ILC3, are more efficient than NCR+ cells in reducing inflammation and prolonging the survival of T2DM mice infected with Mtb. In addition, recombinant IL-22 treatment significantly alleviated insulin resistance in T2DM mice. The gene discussed is IL22; the disease is Insulin resistance.